Canadian Natural Resources Limited Announces 2021 First Quarter Results
Commenting on the Company’s first quarter 2021 results, Tim McKay, President of Canadian Natural stated “The COVID-19 pandemic continues to challenge our everyday living and the way we operate our businesses. With our strong measures in place we have minimized impacts on our operations, but it remains a daily challenge for our field staff to do it safe and do it right. As the global vaccine distribution increases …
Commenting on the Company’s first quarter 2021 results, Tim McKay, President of Canadian Natural stated “The COVID-19 pandemic continues to challenge our everyday living and the way we operate our businesses. With our strong measures in place we have minimized impacts on our operations, but it remains a daily challenge for our field staff to do it safe and do it right. As the global vaccine distribution increases and crude oil demand recovers, especially in the United States, we are seeing
Kiaro Reports 230% Increase in Revenue in Fiscal Year 2021
News provided by
Share this article
Share this article
Record revenues of $17.1 million for fiscal year 2021, an increase of 230%, compared to $5.2 million the year prior
Same store sales increase of 58% year over year
Gross margin of 38.1% for the retail operations during fiscal year 2021 compared to 35% the prior year
General and administrative expense for fiscal year 2021 substantially decreased to 12% of revenue compared to 61% in the prior year
Total HQ salaries decreased to 10% of revenue compared to 46% in the prior year
Convertible debt and accrued interest of $6.5M converted to equity and settlement of $1.75M in promissory notes in fiscal year 2021, leaving only $895K in total principal debt remaining
Gage Cannabis Announces the Grand Opening of Battle Creek Dispensary and Adds Another Dispensary to Retail Portfolio
News provided by
Share this article
Share this article
Gage s eighth retail location is currently welcoming medical patients and will serve adult-use customers in the coming weeks
DETROIT, April 30, 2021 /PRNewswire/ Gage Growth Corp. ( Gage or the Company ) (CSE: GAGE), a leading high-quality craft cannabis brand and operator in Michigan, today announced the grand opening of its eighth provisioning center located in Battle Creek. This announcement comes on the heels of Gage s recent retail expansion in February when the Company opened Cookies Kalamazoo. Patients and customers in Western Michigan will now have access to two Gage provisioning centers. Furthermore, the Company also announced the addition of a provisioning center (dispensary) to its retail portfolio.
TSX-V: OCO) (“
Oroco” or “
Rodriguez”) of Mexico City to acquire 25 shares of Xochipala Gold, S.A. de C.V. (“
Xochipala Gold”) for US$1.5 million. Xochipala Gold holds 100% of the registered title (85% of the beneficial ownership) to the seven core concessions (the “
Core Concessions”) of the Company’s Santo Tomas Project. The shares of Xochipala Gold being acquired currently represent 8.5% of the beneficial ownership of the Core Concessions.
Background: Prior to reaching the current agreements with Rodriguez, the Company’s held all 180 issued shares of Xochipala Gold (the “
Shares”). Mr. Rodriguez held a right to 50 of the Shares, as well as a 0.5% net smelter royalty in the Core Concessions. The Company held an option, through its wholly owned subsidiary Desarrollos Copper, S.A de C.V., to acquire all of Rodriguez’s rights and interest in the Shares for payments totaling US$16 million (the “
PsyBio and Miami University Broaden Partnership Agreement for the Continued Advancement of its Neuropsychiatric Drug Discovery Platform, Expediting its IND Submission to the FDA
News provided by
Share this article
Share this article
PsyBio or the
Company ), a biotechnology company pioneering the next generation of targeted psychoactive medications, announces today that it has amended its master sponsored agreement with Miami University based in Oxford, Ohio (the
Amended Agreement ) to extend and expand the research efforts of the laboratory of Dr. J. Andrew Jones in the Department of Chemical, Paper, and Biomedical Engineering (the
Jones Lab ), to include additional research efforts of the laboratory of Dr. Matthew McMurray in the Department of Psychology (the